Herakles Kritikos

Therapeutic strategies for refractory systemic lupus erythematosus

D. Boumpas, G. Bertsias, P. Sidiropoulos, 2004 .

Perspective on future therapy of vasculitis

D. Boumpas, N. Daskalakis, Herakles Kritikos, 2000, Current rheumatology reports.

Association of a TRAF1 and a STAT4 gene polymorphism with increased risk for rheumatoid arthritis in a genetically homogeneous population.

M. Zervou, G. Goulielmos, D. Boumpas, 2008, Human immunology.

Intestinal ischemia as the first manifestation of vasculitis.

D. Boumpas, I. Diamantis, Z. Saridaki, 2004, Seminars in arthritis and rheumatism.

Rituximab therapy reduces activated B cells in both the peripheral blood and bone marrow of patients with rheumatoid arthritis: depletion of memory B cells correlates with clinical response

H. Papadaki, D. Boumpas, G. Bertsias, 2009, Arthritis research & therapy.

Genetic, immunologic, and immunohistochemical analysis of the programmed death 1/programmed death ligand 1 pathway in human systemic lupus erythematosus.

M. Tzardi, D. Kardassis, C. Mamalaki, 2009, Arthritis and rheumatism.

Association between ulcerative colitis and systemic lupus erythematosus: report of two cases

E. Petinaki, E. Kouroumalis, A. Kapsoritakis, 1998, European journal of gastroenterology & hepatology.